Disc Medicine, Inc. (IRON) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Watertown, MA, United States. El CEO actual es John D. Quisel.
IRON tiene fecha de IPO 2020-08-12, 94 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $2.69B.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
